Relenza 00173-0681-01
Generic: Zanamivir
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Powder
- Route
- Respiratory (inhalation)
- Product Type
- Human Prescription Drug
- Marketing Start
- September 22, 1999
- Listing Expires
- December 31, 2026
- Application
- NDA021036
Need to source Relenza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Zanamivir | 5 mg/1 |
Drug Class
Neuraminidase Inhibitor [EPC]Neuraminidase Inhibitor [EPC]Neuraminidase Inhibitors [MoA]
Selected Package
00173-0681-01Selected5 PACKAGE in 1 CARTON (0173-0681-01) / 4 POWDER in 1 PACKAGE
Other packages for this product(1)
5 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE